Workshop on clinical-trial data and transparency

The European Medicines Agency has announced that it will proactively publish clinical-trial data and enable access to full data sets by interested parties. A number of practical and policy issues need to be addressed before complex data sets can be made available. This workshop is intended to elicit the views, interests, and concerns from a broad range of institutions, groups and individuals to help the Agency define the modalities of proactive access to clinical-trial data. Registration closed.